BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE

10-22-2021 Blog Posts

First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big Profits After Major Rounds of Pandemic Price Hikes Brand name drug makers Johnson & Johnson and Roche kicked off the first round of earnings reports from Big Pharma for the third quarter of the year this week. Both companies bested Wall Street […]

WHAT THEY ARE SAYING: AMERICANS NATIONWIDE CALL ON CONGRESS TO LOWER RX PRICES NOW

10-21-2021 Blog Posts

Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented Momentum to Hold Big Pharma Accountable Prescription drug prices are out-of-control and the momentum for Congress to act is unprecedented. A recent national survey from The Campaign for Sustainable Rx Pricing (CSRxP) found more than one-in-four American voters say they or a family member has […]

ICYMI: AARP POLL FINDS OVERWHELMING MAJORITY OF ARIZONA VOTERS WANT SOLUTIONS TO LOWER RX PRICES

10-15-2021 Blog Posts

New Survey Contributes to Unprecedented Momentum for Congress to Hold Big Pharma Accountable, Tracks Recent Findings Demonstrating Urgency for Action In case you missed it, new polling from AARP Arizona finds that an overwhelming majority of voters in the state support solutions to lower prescription drug prices and want to see their elected officials take […]

ICYMI: VOTERS EXPECT CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES

09-30-2021 Blog Posts

Voters Expect Congress to Hold Big Pharma Accountable and Lower Drug Prices Morning Consult Lauren Aronson September 30, 2021 https://morningconsult.com/opinions/voters-expect-congress-to-hold-big-pharma-accountable-and-lower-drug-prices/   Lawmakers have a historic opportunity to lower prescription drug prices for the American people — and the momentum for action has never been greater as Congress considers solutions to address the national crisis of […]

ICYMI: BIG PHARMA HIKED PRICES ON SPECIALTY DRUGS BY MORE THAN THREE TIMES THE RATE OF INFLATION

09-28-2021 Blog Posts

AARP Report Finds Pharmaceutical Companies’ Price Increases Outpacing Inflation Have  More Than Doubled Costs on Specialty Medicines In case you missed it, AARP’s latest Rx Price Watch report analyses the impact of Big Pharma’s price hikes that exceed the rate of inflation on specialty medicines – a growing category of drugs that are used to […]

SECOND OPINION: BIG PHARMA TROTS OUT BOGUS R&D DEFENSE TO OPPOSE TAX

08-9-2021 Blog Posts

Remembering Drug Companies Spend Their Profits on Shareholders and Marketing — And Price Hikes Are Unrelated to Innovation A recent Wall Street Journal article, “Big Pharma Quietly Pushes Back on Global Tax Deal, Citing Covid-19 Role,” notes brand name drug companies have been deploying the industry’s most favored argument against that proposal, that such a […]

BIG PHARMA EARNINGS WATCH: ASTRAZENECA, SANOFI, MERCK, ABBVIE, ELI LILLY & AMGEN

08-6-2021 Blog Posts

Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand Name Drug Makers Another round of second quarter earnings reports from brand name drug makers AstraZeneca, Sanofi, Merck, AbbVie, Eli Lilly and Amgen showcase yet again that price hikes and anti-competitive tactics continue to be hugely profitable for Big Pharma. All six drug […]

BIG PHARMA EARNINGS WATCH: PFIZER, GLAXO SMITH KLINE, BRISTOL MYERS SQUIBB

07-30-2021 Blog Posts

Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of Price Hikes During Pandemic Brand name drug makers Pfizer, Bristol Myers Squibb, and GlaxoSmithKline (GSK) held earnings calls this week for the second quarter of the year. Each of the earnings calls demonstrated pandemic price hikes continued to be profitable for the […]

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, NOVARTIS, ROCHE

07-22-2021 Blog Posts

New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive Profits After Three Rounds of Price Hikes During Pandemic Brand name drug makers Johnson & Johnson, Novartis, and Roche kicked off another round of earnings reports from Big Pharma for the second quarter of the year this week. All three companies bested […]

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS

07-22-2021 Blog Posts

Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower Drug Prices, Increases Manufacturer Pricing Power Big Pharma is unhappy over the prospect of lawmakers repealing the misguided Rebate Rule. “Despite railing against high drug costs on the campaign trail, lawmakers are threatening to gut a rule that would provide patients meaningful relief […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.